Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Sarla Perf. Fibers Ltd Share Price

₹ 87.43 2.83 (3.34%)

Apr 15 2025 03:30 PM Textiles NSE: SARLAPOLY

Sarla Perf. Fibers Ltd Share Price Update

As of the latest trading session, Sarla Perf. Fibers Ltd share price is currently at 87.43, which is up by 2.83 from its previous closing. Today, the stock has fluctuated between 84.71 and 88.05. Over the past year, Sarla Perf. Fibers Ltd has achieved a return of 41.23 %. In the last month alone, the return has been 10.87 %. Read More...

Sarla Perf. Fibers Ltd Performance

Day Range

Low84.71 High88.05

87.43

52 Week Range

Low 55.00 High 132.30

87.43

Sarla Perf. Fibers Ltd Share Price

14043

526885

SARLAPOLY

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

86.00 Prev. Close

84.60 Volume (Shares)

122272.00

Total traded value

106.90 Upper Circuit

101.52 Lower Circuit

67.68

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Sarla Perf. Fibers Ltd Fundamentals

(Standalone)

Market Cap (Cr)	730.06
PE Ratio (TTM)	12.82
Book Value / Share	60.45
Beta	1.43

ROE	8.26%
EPS (TTM)	6.94
Dividend Yield	0.00%
Net Profit Qtr (Cr)	11.85

Sarla Perf. Fibers Ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	99.93
Operating Expense	84.87
Net Profit	11.85
Net Profit Margin (%)	11.85
Earnings Per Share (EPS)	1.42
EBITDA	23.59
Effective Tax Rate (%)	19.11

Particulars	SEP 2024 (Values in Cr)
Revenue	113.89
Operating Expense	100.06
Net Profit	15.01
Net Profit Margin (%)	13.17
Earnings Per Share (EPS)	2.32
EBITDA	29.79
Effective Tax Rate (%)	30.31

Particulars	JUN 2024 (Values in Cr)
Revenue	110.54
Operating Expense	98.71
Net Profit	16.83
Net Profit Margin (%)	15.22
Earnings Per Share (EPS)	2.02
EBITDA	30.29
Effective Tax Rate (%)	25.16

Particulars	MAR 2024 (Values in Cr)
Revenue	105.35
Operating Expense	93.90
Net Profit	11.21
Net Profit Margin (%)	10.64
Earnings Per Share (EPS)	1.34
EBITDA	22.19
Effective Tax Rate (%)	24.35

Particulars	DEC 2023 (Values in Cr)
Revenue	95.94
Operating Expense	89.38
Net Profit	9.04
Net Profit Margin (%)	9.42
Earnings Per Share (EPS)	1.08
EBITDA	19.29
Effective Tax Rate (%)	25.16

Particulars	MAR 2024 (Values in Cr)
Revenue	382.17
Operating Expense	353.08
Net Profit	37.15
Net Profit Margin (%)	9.72
Earnings Per Share (EPS)	4.45
EBITDA	78.60
Effective Tax Rate (%)	24.93

Particulars	MAR 2023 (Values in Cr)
Revenue	386.55
Operating Expense	356.10
Net Profit	28.81
Net Profit Margin (%)	7.45
Earnings Per Share (EPS)	3.45
EBITDA	65.56
Effective Tax Rate (%)	27.35

Particulars	MAR 2022 (Values in Cr)
Revenue	428.70
Operating Expense	370.23
Net Profit	52.75
Net Profit Margin (%)	12.30
Earnings Per Share (EPS)	6.32
EBITDA	93.02
Effective Tax Rate (%)	25.40

Particulars	MAR 2021 (Values in Cr)
Revenue	251.36
Operating Expense	221.58
Net Profit	12.97
Net Profit Margin (%)	5.15
Earnings Per Share (EPS)	1.55
EBITDA	42.47
Effective Tax Rate (%)	28.87

Particulars	MAR 2020 (Values in Cr)
Revenue	298.32
Operating Expense	279.51
Net Profit	34.53
Net Profit Margin (%)	11.57
Earnings Per Share (EPS)	4.13
EBITDA	64.16
Effective Tax Rate (%)	6.29

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	51.29
ROE %	7.95
ROCE %	9.51
Total Debt to Total Equity	0.30
EBITDA Margin	20.56

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	47.29
ROE %	5.43
ROCE %	7.18
Total Debt to Total Equity	0.31
EBITDA Margin	17.22

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	47.03
ROE %	12.85
ROCE %	13.70
Total Debt to Total Equity	0.38
EBITDA Margin	22.70

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	41.26
ROE %	8.02
ROCE %	8.84
Total Debt to Total Equity	0.63
EBITDA Margin	28.52

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	38.14
ROE %	9.54
ROCE %	7.70
Total Debt to Total Equity	0.83
EBITDA Margin	21.99

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	56.10
ROE %	8.26
ROCE %	9.67
Total Debt to Total Equity	0.27
EBITDA Margin	20.56

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	51.61
ROE %	6.78
ROCE %	8.14
Total Debt to Total Equity	0.28
EBITDA Margin	16.96

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	50.13
ROE %	13.45
ROCE %	13.92
Total Debt to Total Equity	0.36
EBITDA Margin	21.70

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	43.81
ROE %	6.13
ROCE %	9.60
Total Debt to Total Equity	0.44
EBITDA Margin	26.91

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	42.17
ROE %	10.26
ROCE %	9.53
Total Debt to Total Equity	0.47
EBITDA Margin	21.83

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	11.79
Total Assets	650.60
Total Liabilities	650.60
Total Equity	428.37
Share Outstanding	83503000
Price to Book Ratio	0.95
Return on Assets (%)	5.05
Return on Capital (%)	5.84

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	15.71
Total Assets	580.35
Total Liabilities	580.35
Total Equity	395.17
Share Outstanding	83503000
Price to Book Ratio	0.65
Return on Assets (%)	3.67
Return on Capital (%)	4.26

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	67.33
Total Assets	627.44
Total Liabilities	627.44
Total Equity	392.87
Share Outstanding	83503000
Price to Book Ratio	1.13
Return on Assets (%)	7.54
Return on Capital (%)	9

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	97.69
Total Assets	585.03
Total Liabilities	585.03
Total Equity	344.73
Share Outstanding	83503000
Price to Book Ratio	0.55
Return on Assets (%)	4.48
Return on Capital (%)	5.32

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	69.52
Total Assets	658.53
Total Liabilities	658.53
Total Equity	318.29
Share Outstanding	83503000
Price to Book Ratio	0.30
Return on Assets (%)	4.45
Return on Capital (%)	5.33

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	10.30
Total Assets	686.77
Total Liabilities	686.77
Total Equity	468.45
Share Outstanding	83503000
Price to Book Ratio	0.95
Return on Assets (%)	5.40
Return on Capital (%)	6.17

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	14.23
Total Assets	612.36
Total Liabilities	612.36
Total Equity	430.97
Share Outstanding	83503000
Price to Book Ratio	0.65
Return on Assets (%)	4.70
Return on Capital (%)	5.38

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	65.70
Total Assets	649.28
Total Liabilities	649.28
Total Equity	418.58
Share Outstanding	83503000
Price to Book Ratio	1.13
Return on Assets (%)	8.12
Return on Capital (%)	9.59

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	94.87
Total Assets	602.49
Total Liabilities	602.49
Total Equity	365.85
Share Outstanding	83503000
Price to Book Ratio	0.55
Return on Assets (%)	2.15
Return on Capital (%)	2.52

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	68.24
Total Assets	589.03
Total Liabilities	589.03
Total Equity	352.09
Share Outstanding	83503000
Price to Book Ratio	0.30
Return on Assets (%)	5.86
Return on Capital (%)	7.1

Particulars	MAR 2024 (Values in Cr)
Net Income	45.08
Cash from Operations	42.10
Cash from Investing	-56.25
Cash from Financing	23.84
Net change in Cash	-1.39
Free Cash Flow	51.42

Particulars	MAR 2023 (Values in Cr)
Net Income	32.27
Cash from Operations	113.96
Cash from Investing	-55.80
Cash from Financing	-45.50
Net change in Cash	0.70
Free Cash Flow	160.43

Particulars	MAR 2022 (Values in Cr)
Net Income	65.36
Cash from Operations	55.68
Cash from Investing	-25.84
Cash from Financing	-17.62
Net change in Cash	-6.83
Free Cash Flow	89.05

Particulars	MAR 2021 (Values in Cr)
Net Income	35.44
Cash from Operations	37.00
Cash from Investing	30.95
Cash from Financing	-56.18
Net change in Cash	4.34
Free Cash Flow	49.77

Particulars	MAR 2020 (Values in Cr)
Net Income	31.57
Cash from Operations	54.27
Cash from Investing	-47.53
Cash from Financing	3.19
Net change in Cash	0.57
Free Cash Flow	78.93

Particulars	MAR 2024 (Values in Cr)
Net Income	49.48
Cash from Operations	42.86
Cash from Investing	-55.57
Cash from Financing	22.36
Net change in Cash	-1.41
Free Cash Flow	51.95

Particulars	MAR 2023 (Values in Cr)
Net Income	39.66
Cash from Operations	118.04
Cash from Investing	-54.07
Cash from Financing	-51.20
Net change in Cash	0.86
Free Cash Flow	162.16

Particulars	MAR 2022 (Values in Cr)
Net Income	70.70
Cash from Operations	58.01
Cash from Investing	-24.74
Cash from Financing	-19.90
Net change in Cash	-5.65
Free Cash Flow	90.28

Particulars	MAR 2021 (Values in Cr)
Net Income	18.24
Cash from Operations	50.50
Cash from Investing	-16.16
Cash from Financing	-24.30
Net change in Cash	2.80
Free Cash Flow	64.90

Particulars	MAR 2020 (Values in Cr)
Net Income	36.86
Cash from Operations	48.53
Cash from Investing	-33.65
Cash from Financing	-4.15
Net change in Cash	1.50
Free Cash Flow	69.32

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ARVIND LIMITED	333.10	28.94	2.48	8721.16	271.55 / 450.40
BLUE BLENDS (INDIA) LTD.	0.97	0.00	-0.04	2.10	0.00 / 0.00
BOMBAY DYEING & MFG. CO L	126.80	30.41	1.04	2618.86	117.25 / 256.25
CENTURY ENKA LTD	498.50	13.62	0.77	1089.22	416.00 / 863.90

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ARVIND LIMITED	333.10	37.05	2.55	8721.16	271.55 / 450.40
BLUE BLENDS (INDIA) LTD.	0.97	0.00	-0.04	2.10	0.00 / 0.00
BOMBAY DYEING & MFG. CO L	126.80	30.55	1.05	2618.86	117.25 / 256.25
CENTURY ENKA LTD	498.50	13.54	0.77	1089.22	416.00 / 863.90

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 82.40
26 Days 80.10
10 Days 81.30
50 Days 82.20
12 Days 81.00
100 Days 86.20
20 Days 80.20
200 Days 86.50

84.97
PIVOT

First Resistance	86.13
Second Resistance	87.67
Third Resistance	88.83

First Support	83.43
Second Support	82.27
Third Support	80.73

RSI	56.21
MACD	0.87
Commodity Channel Index (CCI)	117.17

ADX	21.02
Williams % R	-19.31

Sarla Perf. Fibers Ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

41.51 Promoter Holdings

56.89 FII

0.8 DII

0.78 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Satidham Industries Pvt.ltd.	Shareholding of Promoter and Promoter Group	2.4127297E7	28.89
Sarladevi Madhusudan Jhunjhunwala As A Partner Of Hindustan Cotton Company	Shareholding of Promoter and Promoter Group	1.1487389E7	13.76
Sarladevi Madhusudan Jhunjhunwala	Shareholding of Promoter and Promoter Group	3894000.0	4.66
Krishna Madhusudan Jhunjhunwala	Shareholding of Promoter and Promoter Group	3269000.0	3.91
Anil Kumar Goel	Public Shareholding	2500000.0	2.99
Madhusudan Jhunjhunwala And Sons Huf .	Shareholding of Promoter and Promoter Group	2469596.0	2.96
Dalal & Broacha Stock Broking Pvt.ltd.	Public Shareholding	1670000.0	2.0
Seema Goel	Public Shareholding	1000000.0	1.2
Vijaya S	Public Shareholding	1000000.0	1.2
Krishnamurthy Narayanan Iyer	Public Shareholding	873478.0	1.05
Vrinda Krishna Jhunjhunwala	Shareholding of Promoter and Promoter Group	880252.0	1.05
Kanav Krishna Jhunjhunwala	Shareholding of Promoter and Promoter Group	647000.0	0.77
Krishnakumar And Sons Huf .	Shareholding of Promoter and Promoter Group	325000.0	0.39
Harmony Estates Pvt Ltd	Shareholding of Promoter and Promoter Group	260095.0	0.31
Sarla Estate Developers Pvt Ltd	Shareholding of Promoter and Promoter Group	145537.0	0.17
Neha Krishna Jhunjhunwala	Shareholding of Promoter and Promoter Group	4000.0	0.0

Sarla Perf. Fibers Ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2022-09-20	2.0	Final	2022-09-21	Equity shares	2019-09-18	1.1	Final	2019-09-20	Equity shares	2018-09-18	1.1	Final	2018-09-21	Equity shares	2017-09-21	1.1	Final	2017-09-23	Equity shares	2016-09-22	0.25	Final	2016-09-24	Equity shares	2016-03-22	0.8	Interim	2016-03-23	Equity shares	2015-09-22	8.0	Final	2015-09-24	Equity shares	2014-09-19	7.5	Final	2014-09-23	Equity shares	2013-09-05	6.0	Final	2013-09-07	Equity shares	2012-09-11	5.0	Final	2012-09-13	Equity shares	2011-09-20	4.5	Final	2011-09-22	Equity shares	2010-09-16	3.5	Final	2010-09-18	Equity shares	2009-09-23	3.5	Final	2009-09-25	Equity shares	2008-09-22	3.5	Final	2008-09-24	Equity shares	2007-09-20	3.0	Final	2007-09-24	Equity shares	2005-09-19	0.0	Final	2005-09-21	Equity shares

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read